Comparison of the Cobas 4800 HPV test and the Seeplex HPV4A ACE with the hybrid capture 2 test

International Journal of Medical Sciences

Volumn 10, Issue 2, 2012, Pages 119-123

  Ki, Eun Young ^a   Kim, Hee Eun ^a   Choi, Yeong Jin ^a   Park, Jong Sup ^a   Kang, Chang Seok ^a   Lee, Ahwon ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

HC 2; HPV DNA; Multiplex PCR; Real time PCR

Indexed keywords

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DNA EXTRACTION; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; INTERMETHOD COMPARISON; LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRECANCER; SENSITIVITY AND SPECIFICITY; SOUTH KOREA; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

HC 2; HPV DNA; MULTIPLEX PCR.; REAL-TIME PCR;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; PAPILLOMAVIRUS INFECTIONS; VAGINAL SMEARS;

EID: 84872158793     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5460     Document Type: Article

References (14)

1. Li J, Zhang D, Zhang Y, Wang X, Lin Y, Hu L. Prevalence and genotype distribution of human papillomavirus in women with cervical cancer or high-grade precancerous lesions in Chengdu, western China. Int J Gynaecol Obstet, 2011;112(2): 131-4.
2. Schiffman M, Castle P E, Jeronimo J, Rodriguez A C, Wacholder S. Hu-man papillomavirus and cervical cancer. Lancet, 2007;370(9590): 890-907
3. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Cage J C, Castle P E. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst, 2011; 103(5): 368-83.
4. Cuzick J, Cubie H, Hulman G, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet, 2003;362: 1871-6.
5. Arbyn M, Saseini P, Meijer CJLM, Clavel C, Koliopoulos G, Diller J. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine. 2006; 24 Suppl 3: 78-89.
6. Brink AA, Snijder P J F, Meijer C J L.M, Berkhof J, Verheijen R H M. HPV testing in cervical screening. Best Pract Res Clin Obstet Gynaecol, 2006; 20(2): 253-66.
7. Wong AA, Fuller J, Pabbaraju K, Wong S, Zahariadis G. Comparison of the hybrid capture 2 and cobas 4800 tests for detection of high-risk human papillomavirus in specimens collected in PreservCyt medium. J Clin Microbiol, 2012; 50(1): 25-9.
8. Gustafsson L, Poten J, Bergstrom R, Adami HO. International incidence rates of invasive cervical cancer before cytologic screening. Int J Cancer, 1997;71: 159-165.
9. Shalini L, Kulasingam JPH, Nancy B Kiviat, Constance Mao, Noel S. Weiss, Jane M Kuypers, Laura A Koutsky. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: Comparison of Sensitivity,Specificity and Freqency of Referral. JAMA, 2002;288(14): 1749-1757.
10. Castle PE, Stoler MH, Wright TC Jr, Sharma A, Wright TL, Behrens CM. Performance of carcinogenic human papillomavirus (HPV) testing and HPV 16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and old: a subanalysis of the ATHENA study. Lancet Oncol, 2011;12: 880-890.
11. Mateos Lindemann ML, Dominguez MJR, Antonio JC, et al. Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes. J Mol Diagn, 2012; 14(1): 65-70.
12. Martinez SB, Palomares JC, Artura A, et al. Comparison of the Cobas 4800 Human Papillomavirus test against a combination of the Amplicor Human Papillomavirus and the Linear Array tests for detection of HPV types 16 and 18 in cervical samples. J Virol Methods, 2012; 180(1-2): 7-10.
13. Gage JC, Sadorra M, LaMere BJ, et al. Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests. J Clin Microbiol, 2012; 50(1): 61-5.
14. Min KJ, So KA, Lee JE, et al. Comparison of the Seeplex HPV4A ACE and the Cervista HPV assays for the detection of HPV in hybrid capture 2 positive media. J Gynecol Oncol, 2012; 23(1): 5-10.